 <h1>Evolocumab Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to evolocumab: subcutaneous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, evolocumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking evolocumab:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty with breathing or swallowing</li>
<li>fever</li>
<li>hives, itching, or rash</li>
<li>nausea</li>
<li>reddening of the skin, especially around the ears</li>
<li>swelling of the eyes, face, or inside of the nose</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of evolocumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>dry mouth</li>
<li>ear congestion</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>loss of voice</li>
<li>muscle aches</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stomach ache</li>
<li>stuffy or runny nose</li>
<li>sweating</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>diarrhea</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with moving</li>
<li>dizziness</li>
<li>frequent urge to urinate</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle or joint pain</li>
<li>muscle stiffness</li>
<li>nervousness</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>pounding in the ears</li>
<li>slow or fast heartbeat</li>
<li>swollen joints</li>
</ul><p>
<!-- end subcutaneous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to evolocumab: subcutaneous solution</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included nasopharyngitis, upper respiratory tract infection, back pain, and injection site reactions.</p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity reactions (including rash, eczema, erythema, urticaria)</p>
<p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastroenteritis, nausea (1.8%)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction (including erythema, pain, bruising)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, myalgia, musculoskeletal pain, arthralgia (1.8%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Neurocognitive events (0.2%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Influenza, fatigue (1.6%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Contusion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Influenza, fatigue (1.6%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Contusion<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Development anti-drug antibody<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Repatha (evolocumab)." Amgen USA, Thousand Oaks, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Praluent vs Repatha: What's the difference?</li>
<li>Can you drink alcohol and take Repatha?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about evolocumab</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>355 Reviews</li>
<li>Drug class: PCSK9 inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Evolocumab Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Repatha</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Cardiovascular Risk Reduction</li>
<li>High Cholesterol</li>
<li>High Cholesterol, Familial Heterozygous</li>
<li>High Cholesterol, Familial Homozygous</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to evolocumab: subcutaneous solution</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included nasopharyngitis, upper respiratory tract infection, back pain, and injection site reactions.</p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity reactions (including rash, eczema, erythema, urticaria)</p><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastroenteritis, nausea (1.8%)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction (including erythema, pain, bruising)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, myalgia, musculoskeletal pain, arthralgia (1.8%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Neurocognitive events (0.2%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Influenza, fatigue (1.6%)</p><p><b>Uncommon</b> (0.1% to 1%): Contusion<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Influenza, fatigue (1.6%)</p><p><b>Uncommon</b> (0.1% to 1%): Contusion<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (less than 0.1%): Development anti-drug antibody<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Repatha (evolocumab)." Amgen USA, Thousand Oaks, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Praluent vs Repatha: What's the difference?</li>
<li>Can you drink alcohol and take Repatha?</li>
</ul><h2>More about evolocumab</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>355 Reviews</li>
<li>Drug class: PCSK9 inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Evolocumab Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cardiovascular Risk Reduction</li>
<li>High Cholesterol</li>
<li>High Cholesterol, Familial Heterozygous</li>
<li>High Cholesterol, Familial Homozygous</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>